Therapeutic optimization study based on MR enterocolonography in patients with Crohn's disease

Phase 3

• Conditions: Crohn' s disease

• Registration Number: JPRN-UMIN000017781
• Lead Sponsor: Department of Gastroenterology and Hepatology Tokyo Medical and Dental University

Brief Summary

A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-02
• Study Completion: 2021-03-31
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Not provided

Exclusion Criteria

Contraindication for infliximab, adalimumab, or azathioprine Lactating woman Presence of malignancy Within 3 month from intestinal surgery Presence of an end stoma Planned surgery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is the rate of clinical remission(CDAI<150) at 104 weeks.

Secondary Outcome Measures

Name	Time	Method
CDAI, operation, hospitalizasion, SES-CD, anctivity of MREC and MaRIA, safety